Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2008
10/29/2008EP1984399A2 Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps
10/29/2008EP1984396A2 Inhibitors specific of presenilin-1 and their uses
10/29/2008EP1984020A2 Means and methods for modulating stem cell mobilization
10/29/2008EP1786827A4 Methods for immunoglobulin purification
10/29/2008EP1737958B1 Compositions and methods for inducing anti-tumor immunity
10/29/2008EP1582218B1 Compositions for the treatment of mycobacterial infections
10/29/2008EP1509547B1 Antobodies to adipose tissues
10/29/2008EP1441764B1 Antigen arrays comprising rankl for treatment of bone disease
10/29/2008EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
10/29/2008EP1156823B1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/29/2008EP1116791B1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
10/29/2008EP1071460B1 INTERNALIZING ErbB2 ANTIBODIES
10/29/2008EP1054693B1 Inhibitors of complement activation
10/29/2008EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
10/29/2008EP0961831B1 Human endokine alpha
10/29/2008EP0752872B1 Nadh oxidase as a target in diagnosis and therapy
10/29/2008EP0660721B1 Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
10/29/2008CN101296944A Engineered anti-IL-23 antibodies
10/29/2008CN101294164A Expression of recombinant human metaphase factor (rh-Midkine), preparation and application of monoclone antibody
10/29/2008CN101294162A P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
10/29/2008CN101294159A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection
10/29/2008CN101294147A Monoclone antibody of swine fever virus resistant wild strain E2 protein, preparation method and application thereof
10/29/2008CN101293930A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection
10/29/2008CN101293924A Monoclone antibody with combined function epiposition, specificity of osteopontin and in preparing antineoplastic diversion medicaments
10/29/2008CN101293922A Streptococcus pneumoniae proteins and nucleic acid molecules
10/29/2008CN101293921A Streptococcus pneumoniae proteins and nucleic acid molecules
10/29/2008CN101293916A Monoclone antibody with combined function epiposition, specificity of osteopontin and uses thereof
10/29/2008CN101293912A Conjugate for contructing cationised carrier protein and aflatoxin B1 with one-step method
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100429231C Method for removing beta-lactoglobulin in milk and extracting high purity immune globulin
10/29/2008CN100429230C Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
10/29/2008CN100429225C Promyostatin peptides and methods of using same
10/28/2008US7442783 Natural IgM antibodies and inhibitors thereof
10/28/2008US7442781 Diagnosis, prevention and treatment of cancer
10/28/2008US7442779 Isolation of proteins
10/28/2008US7442778 Modified Fc molecules
10/28/2008US7442777 Cytotoxicity mediation of cells evidencing surface expression of CD63
10/28/2008US7442776 production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds,
10/28/2008US7442775 Humanized anti-CCR2 antibodies and methods of use therefor
10/28/2008US7442773 Biological scaffold comprising src, major histocompatibility and/or pdz domains for use as diagnostic tool in detection of metabolic disorders
10/28/2008US7442772 Monoclonal antibody which recognizes membrane proteins for use in the treatment and prevention of cell proliferative, inflammatory and nervous system disorders
10/28/2008US7442769 Antifreeze proteins from basidiomy cetes
10/28/2008US7442765 PRO polypeptides; fused to heterologous polypeptide sequences
10/28/2008US7442761 Coronavirus amino acid sequences for use in prevention and treatment of infection and cell proliferative disorders
10/28/2008US7442534 Nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
10/28/2008US7442522 Nucleic acids encoding chromo or fluorescent proteins and method for using the same
10/28/2008US7442521 To generate transgenic, non-human plants or animals or site specific gene modifications in cell lines; fluorescent proteins high through-put screening assays; use as biosensors in prokaryotic and eukaryotic cells, fluorescence activated cell sorting applications, as markers following injection into cells
10/28/2008US7442516 Antibody specific to central nervous system tau protein
10/28/2008US7442514 Mutants of the factor VII-activating protease and detection methods using specific antibodies
10/28/2008US7442513 Method of screening for agents that modulate a homer signaling pathway
10/28/2008US7442497 Methods of determining chronic hepatitis C infection
10/28/2008US7442376 Glycoprotein hormone compositions containing two β subunits
10/28/2008US7442373 Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax
10/28/2008CA2391808C Method for treatment of symptoms of central nervous system disorders
10/28/2008CA2225924C Recombinant mistletoe lectin
10/28/2008CA2167321C Reagents and methods for the detection and quantification of testosterone in fluid samples
10/23/2008WO2008127973A1 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
10/23/2008WO2008127735A1 Il3ralpha antibody conjugates and uses thereof
10/23/2008WO2008127711A2 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008WO2008127680A2 Diagnosis and treatment of diseases caused by misfolded proteins
10/23/2008WO2008127656A1 Targeting abcb5 for cancer therapy
10/23/2008WO2008127655A1 Anti-alpha 6 beta 4 integrin antibodies and uses therof
10/23/2008WO2008127347A1 Pro115 antibody compositions and methods of use
10/23/2008WO2008127305A2 Method of isolating biomacromolecules using low ph and divalent cations
10/23/2008WO2008127285A2 Target peptides for ovarian cancer immunotherapy
10/23/2008WO2008127271A2 Interleukin -13 binding proteins
10/23/2008WO2008127248A1 Gene defects and mutant alk kinase in human solid tumors
10/23/2008WO2008127105A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof
10/23/2008WO2008127102A1 S. pnuemoniae transcytosis protein
10/23/2008WO2008127099A1 Prevention of staphylococcus biofilm formation
10/23/2008WO2008126847A1 Prophylactic or therapeutic agent for cancer
10/23/2008WO2008126517A1 Novel slc17-type transporter protein in mammal and use thereof
10/23/2008WO2008126065A2 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/23/2008WO2008125985A2 Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes
10/23/2008WO2008125733A1 Immunoassay for quantification of an unstable antigen selected from bnp and probnp
10/23/2008WO2008125623A2 Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9)
10/23/2008WO2008125307A1 Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE
10/23/2008WO2008124933A1 Carbon and nitrogen-regulating gene and protein and modulation thereof
10/23/2008WO2008124858A2 Targeted receptor
10/23/2008WO2008103849A3 Methods and compounds for lymphoma cell detection and isolation
10/23/2008WO2008086335A3 Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
10/23/2008WO2008076981A3 Inhibitors of ll-37- mediated immune reactivity to self nucleic acids
10/23/2008WO2008060705A3 Anti-dll4 antibodies and methods using same
10/23/2008WO2008053330A3 Monoclonal antibodies against the human anti-mullerian hormone type ii receptor (amhr-ii)
10/23/2008WO2008043822A3 Amino acid sequences that bind to a desired molecule in a conditional manner
10/23/2008WO2008031020A3 Arginine wash in protein purification using affinity chromatography
10/23/2008WO2008025020A3 Cd30 binding agents and uses thereof
10/23/2008WO2008019291A3 Anti-alix antibodies and hybridomas
10/23/2008WO2007143295A3 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
10/23/2008WO2007139997A3 Methods for site-specific pegylation
10/23/2008WO2007134274A3 Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy
10/23/2008WO2007123765A3 Neutrokine-alpha and neutrokine-alpha splice variant
10/23/2008WO2007120626A3 Uses and compositions for treatment of ankylosing spondylitis
10/23/2008WO2007109668A3 Compositions and methods for improving bone mass through modulation of novel receptors of pth and fragments thereof
10/23/2008WO2007109254A3 Stabilized polypeptide compositions
10/23/2008WO2007106707A3 Identification and engineering of antibodies with variant heavy chains and methods of using same
10/23/2008WO2007095746A9 Cancerous disease modifying antibodies
10/23/2008WO2007065037A3 Antibodies against mmp-13 (collagenase-3) and uses thereof
10/23/2008WO2007048127A3 Fc labeling for immunostaining and immunotargeting
10/23/2008WO2006135799A3 Detection of hookworm coproantigens
1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 1494